上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于迈得医疗工业设备股份有限公司 2025 年第一次临时股东大会的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于迈得医疗工业设备股份有限公司 2025 年第一次临时股东大会的法律意见书 致：迈得医疗工业设备股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受迈得医疗工业设备股份 有限公司（以下简称"公司"）的委托，就公司召开 2025 年第一次临时股东大 会（以下简称"本次股东大会"）的有关事宜，根据《中华人民共和国公司法》 （以下简称"《公司法》"）《中华人民共和国证券法》（以下简称"《证券法》"） 等相关法律、法规和规范性文件以及《迈得医疗工业设备股份有限公司章程》（以 下简称"《公司章程》"）等内部规章制度的有关规定，出具本法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（ ...

一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 10 月 30 日 （二） 股东大会召开的地点：浙江省玉环市沙门镇滨港工业城迈得医疗工业设 备股份有限公司会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： 证券代码：688310 证券简称：迈得医疗 公告编号：2025-043 迈得医疗工业设备股份有限公司 2025 年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 | 1、出席会议的股东和代理人人数 | 18 | | --- | --- | | 普通股股东人数 | 18 | | 2、出席会议的股东所持有的表决权数量 | 109,156,259 | | 普通股股东所持有表决权数量 | 109,156,259 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比例（%） | 66.7103 | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 66.7103 ...

证券代码：688310 证券简称：迈得医疗 公告编号：2025-045 迈得医疗工业设备股份有限公司 迈得医疗工业设备股份有限公司（以下简称"公司"）第五届董事会第六次会 议（以下简称"本次会议"）于 2025 年 10 月 30 日以现场加通讯的方式在公司会 议室召开。本次会议于 2025 年第一次临时股东大会结束后，通知公司第五届董 事会全体董事参加会议，经全体董事同意，豁免了本次会议通知关于时限的要求， 召集人已在会议上作出说明。本次会议由董事长林军华先生主持，应出席会议董 事 8 人，实际出席会议董事 8 人。本次会议的召开符合《中华人民共和国公司法》 等法律、行政法规以及《迈得医疗工业设备股份有限公司章程》（以下简称"公 司章程"）的相关规定。 二、董事会会议审议情况 经与会董事审议表决，通过了如下议案： 第五届董事会第六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 表决结果：同意：8 票；反对：0 票；弃权：0 票。 (二)审议通过了《关于确认董事会审计委员会成员和召集 ...

Market Overview - The automation equipment sector experienced a slight decline of 0.05% on the previous trading day, with Xinjing Intelligent leading the drop [1] - The Shanghai Composite Index closed at 3988.22, down 0.22%, while the Shenzhen Component Index closed at 13430.1, down 0.44% [1] Stock Performance - Notable gainers in the automation equipment sector included: - Tianzhong Precision Machinery (300461) with a closing price of 21.39, up 10.66% and a trading volume of 147,800 shares, totaling 308 million yuan [1] - Weichuang Electric (688698) closed at 88.75, up 9.47% with a trading volume of 100,400 shares, totaling 850 million yuan [1] - Dameng Technology (603025) closed at 20.56, up 6.36% with a trading volume of 614,100 shares, totaling 1.233 billion yuan [1] - Conversely, Xinjing Intelligent (301112) saw a significant decline of 13.96%, closing at 52.27 with a trading volume of 121,400 shares, totaling 667 million yuan [2] - Other notable decliners included: - Maid Medical (688310) down 5.47% to 19.88 [2] - Guangyun Da (300227) down 5.32% to 9.96 [2] Capital Flow - The automation equipment sector experienced a net outflow of 1 billion yuan from institutional investors, while retail investors saw a net inflow of 704 million yuan [2] - The capital flow for specific stocks showed: - Huichuan Technology (300124) had a net inflow of 95.57 million yuan from institutional investors [3] - Weichuang Electric (688698) saw a net inflow of 78.95 million yuan from institutional investors [3] - Jietong Technology (603025) had a net inflow of 41.88 million yuan from institutional investors [3]

Core Viewpoint - Midea Medical experienced a decline of 5.33% in stock price, reaching 19.91 CNY per share, with a total market capitalization of 3.309 billion CNY as of October 28 [1] Company Overview - Midea Medical Industrial Equipment Co., Ltd. is located in Yuhuan City, Zhejiang Province, established on March 10, 2003, and listed on December 3, 2019 [1] - The company's main business involves the research, production, sales, and service of medical consumable intelligent equipment [1] - Revenue composition includes: 48.75% from safe infusion products, 26.27% from blood purification, and 24.98% from other categories [1] Shareholder Information - Among the top circulating shareholders, one fund from Huaxia Fund holds a significant position, having reduced its holdings by 1.0661 million shares in Q3, now holding 2.6036 million shares, which is 1.57% of circulating shares [2] - The Huaxia Industry Prosperity Mixed A Fund (003567) was established on February 4, 2017, with a current scale of 7.261 billion CNY and a year-to-date return of 56.47%, ranking 837 out of 8155 in its category [2] - The fund manager, Zhong Shuai, has a tenure of 5 years and 94 days, with the best fund return during this period being 177.53% and the worst being -2.4% [2]

Core Insights - Midea Medical (688310.SH) reported its Q3 2025 results, revealing that as of October 27, 2025, six institutional investors held a total of 14.056 million shares, representing 8.46% of the company's total equity. This marks a decrease of 1.83 percentage points in institutional ownership compared to the previous quarter [1] Group 1: Institutional Investors - Six institutional investors disclosed their holdings in Midea Medical, with a total shareholding of 14.056 million shares, accounting for 8.46% of the total equity [1] - The institutional ownership decreased by 1.83 percentage points compared to the previous quarter [1] Group 2: Public Funds - One public fund, Huaxia Industry Prosperity Mixed A, reported a decrease in holdings, with a reduction of 0.64% compared to the previous quarter [2] - Two new public funds were disclosed this quarter, including the交银稳健配置混合 and 交银科技创新灵活配置混合A [2] - A total of 49 public funds were not disclosed this quarter, including several notable funds such as Huaxia Vision Growth One-Year Holding Mixed A and Guotai Xinge Youxuan One-Year Holding Mixed A [2] Group 3: Social Security Funds - One social security fund, Huaxia Fund Management Co., Ltd. - Social Security Fund 422 Combination, reported a decrease in holdings, with a reduction of 0.34% compared to the previous quarter [2]

Core Viewpoint - The company announced the postponement of its fundraising project related to the expansion of smart medical equipment, moving the expected operational date from November 2025 to November 2026 due to various operational adjustments and project delays [13][24][25]. Financial Data - The company reported that the total amount raised from its initial public offering was RMB 518.11 million, with a net amount of RMB 457.35 million after deducting issuance costs [18][19]. - The company has established special accounts for the management of raised funds, ensuring that all funds are stored in designated accounts [19]. Shareholder Information - As of September 30, 2025, the company held 2,592,575 shares in its repurchase special securities account [5]. - The company has not reported any changes in the shareholding structure of its top ten shareholders or any significant shareholder lending activities [6][7]. Board Meeting Decisions - The fifth board meeting held on October 27, 2025, approved the third-quarter report and the postponement of the fundraising project [10][13]. - All board members present voted in favor of the resolutions, indicating unanimous support for the decisions made [11][14]. Project Postponement Details - The postponement of the smart medical equipment expansion project is attributed to production layout adjustments and the need for further optimization in construction [24]. - The company emphasized that this delay does not affect the project's content, implementation, or investment scale, ensuring compliance with relevant regulations [25][28]. Monitoring and Compliance - The supervisory board has also approved the postponement, affirming that it aligns with regulatory requirements and does not harm the interests of the company or its shareholders [33][34]. - The company will continue to monitor market conditions and optimize resource allocation to ensure the project's successful completion [25].

Core Insights - The company reported a total revenue of 225 million yuan for Q3 2025, with a net profit attributable to shareholders of 8.84 million yuan and a net cash inflow from operating activities of 126 million yuan [1]. Financial Performance - The latest debt-to-asset ratio stands at 29.86%, which is an increase of 1.49 percentage points from the previous quarter and an increase of 13.62 percentage points compared to the same period last year [3]. - The company's gross profit margin is 40.19%, reflecting a decrease of 6.70 percentage points from the same period last year [3]. - The return on equity (ROE) is reported at 1.10% [3]. - The diluted earnings per share (EPS) is 0.05 yuan [3]. - The total asset turnover ratio is 0.20 times, while the inventory turnover ratio is 0.80 times [3]. Shareholder Structure - The number of shareholders is 4,528, with the top ten shareholders holding a total of 120 million shares, accounting for 72.36% of the total share capital [3]. - The largest shareholder is Lin Junhua, holding 47.1 million shares [3]. - Other notable shareholders include Chen Wanshun with 14.8 million shares and Taizhou Saina Investment Consulting Partnership with 3.45 million shares [3].

Core Viewpoint - The announcement from Maide Medical indicates a delay in the completion of its project due to various operational adjustments, which may impact future production timelines and investor sentiment [1]. Group 1: Company Performance - As of October 27, 2025, Maide Medical's stock closed at 21.03 yuan, reflecting a 0.62% increase from the previous trading day [1]. - The company's total market capitalization is reported at 3.496 billion yuan [1]. - The stock opened at 20.88 yuan, reached a high of 21.44 yuan, and a low of 20.71 yuan, with a trading volume of 48.8183 million yuan and a turnover rate of 1.4% [1]. Group 2: Project Update - Maide Medical announced the use of 64.2129 million yuan of raised funds for the "Annual Production of 35 Medical Equipment Combination Intelligent Equipment Expansion Project" [1]. - Due to production layout adjustments, construction optimization, and equipment procurement and installation challenges, the project’s expected operational date has been postponed from November 2025 to November 2026 [1]. - This decision has been approved by the company's board of directors and supervisory board, with no objections from the sponsor, GF Securities Co., Ltd. [1].

迈得医疗(688310.SH)披露2025年第三季度报告，公司前三季度实现营收2.25亿元，同比增长2.31%;归母 净利润884万元，同比增长15.82%;扣非净利润亏损128万元;基本每股收益0.05元。 ...